Proteomics of Mouse Heart Ventricles Reveals Mitochondria and Metabolism as Major Targets of a Post-Infarction Short-Acting GLP1Ra-Therapy

Cardiovascular disease is the main cause of death worldwide, making it crucial to search for new therapies to mitigate major adverse cardiac events (MACEs) after a cardiac ischemic episode. Drugs in the class of the glucagon-like peptide-1 receptor agonists (GLP1Ra) have demonstrated benefits for he...

Descripción completa

Detalles Bibliográficos
Autores principales: de Freitas Germano, Juliana, Sharma, Ankush, Stastna, Miroslava, Huang, Chengqun, Aniag, Marianne, Aceves, Angie, Van Eyk, Jennifer E., Mentzer, Robert M., Piplani, Honit, Andres, Allen M., Gottlieb, Roberta A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395861/
https://www.ncbi.nlm.nih.gov/pubmed/34445425
http://dx.doi.org/10.3390/ijms22168711

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395861/
https://www.ncbi.nlm.nih.gov/pubmed/34445425
http://dx.doi.org/10.3390/ijms22168711

Ejemplares similares